Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Alpine Immune Sciences, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +3 vs. Q4 2021
- Shares held
- 24.7M
- +6.16M (+33.2%) vs. Q4 2021
- Total value
- $221.8M
- −$35.3M (−13.7%) vs. Q4 2021
- New holders
- 10
- 16 more added
- Sold out
- 7
- 17 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 180 | $2.56B |
| Q4 2023 | 133 | $1.12B |
| Q3 2023 | 88 | $525.8M |
| Q2 2023 | 77 | $449.3M |
| Q1 2023 | 61 | $319.4M |
| Q4 2022 | 64 | $300.8M |
| Q3 2022 | 70 | $284.0M |
| Q2 2022 | 58 | $204.4M |
| Q1 2022 | 56 | $221.8M |
| Q4 2021 | 53 | $257.1M |
| Q3 2021 | 44 | $163.5M |
| Q2 2021 | 47 | $118.5M |
| Q1 2021 | 48 | $145.0M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Alpine Immune Sciences, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 85 | $1.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 266 | $2.00K | 0.00% | +266 | New |
| Royal Bank of Canada | 713 | $6.00K | 0.00% | −1,899−72.7% | Reduced |
| Ameritas Investment Partners, Inc. | 911 | $8.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,043 | $9.00K | 0.00% | −2,723−72.3% | Reduced |
| Legal & General Group Plc | 1,227 | $11.0K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,886 | $17.0K | 0.00% | −12,212−86.6% | Reduced |
| Amalgamated Bank | 1,891 | $17.0K | 0.00% | +1,891 | New |
| Amalgamated Financial Corp. | 1,891 | $17.0K | 0.00% | +1,891 | New |
| Tower Research Capital LLC (TRC) | 2,004 | $18.0K | 0.00% | +1,199+148.9% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,257 | $20.0K | 0.00% | +2,257 | New |
| UBS Group AG | 2,369 | $22.0K | 0.00% | −2,627−52.6% | Reduced |
| BNP Paribas Arbitrage, SA | 3,777 | $33.9K | 0.00% | +531+16.4% | Added |
| California State Teachers Retirement System | 4,967 | $45.0K | 0.00% | −1,183−19.2% | Reduced |
| New York State Common Retirement Fund | 5,397 | $48.0K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 5,500 | $49.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 5,703 | $51.0K | 0.00% | −3,735−39.6% | Reduced |
| American International Group, Inc. | 5,767 | $52.0K | 0.00% | −406−6.6% | Reduced |
| Deutsche Bank AG | 6,300 | $57.0K | 0.00% | −742−10.5% | Reduced |
| JPMorgan Chase & Co | 8,947 | $80.0K | 0.00% | +1,697+23.4% | Added |
| Morgan Stanley | 9,277 | $83.0K | 0.00% | +132+1.4% | Added |
| Susquehanna International Group, LLP | 12,421 | $111.0K | 0.00% | +12,421 | New |
| Hikari Power Ltd | 12,445 | $112.0K | 0.01% | +2,000+19.1% | Added |
| Bank of America Corp | 15,442 | $138.0K | 0.00% | +10,498+212.3% | Added |
| Allspring Global Investments Holdings, LLC | 16,862 | $151.0K | 0.00% | +10,835+179.8% | Added |
| Nuveen Asset Management, LLC | 18,446 | $160.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 22,850 | $205.0K | 0.00% | +9,471+70.8% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 28,316 | $254.0K | 0.00% | +9,290+48.8% | Added |
| Kingsbury Capital Investment Advisors LLC | 29,153 | $262.0K | 0.29% | +29,153 | New |
| Alps Advisors Inc | 30,030 | $269.0K | 0.00% | −3,785−11.2% | Reduced |
| Charles Schwab Investment Management Inc | 32,417 | $291.0K | 0.00% | +2,294+7.6% | Added |
| Walleye Capital LLC | 41,746 | $374.0K | 0.01% | −68,353−62.1% | Reduced |
| Two Sigma Investments, LP | 47,708 | $428.0K | 0.00% | −31,974−40.1% | Reduced |
| Bank of New York Mellon Corp | 49,155 | $441.0K | 0.00% | −2,590−5.0% | Reduced |
| Dimensional Fund Advisors LP | 53,064 | $476.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 101,708 | $912.0K | 0.00% | −3,887−3.7% | Reduced |
| Ensign Peak Advisors, Inc | 110,017 | $987.0K | 0.00% | +37,087+50.9% | Added |
| Two Sigma Advisers, LP | 114,175 | $1.02M | 0.00% | +6,400+5.9% | Added |
| Tiger Management L.L.C. | 137,728 | $1.24M | 0.33% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 138,279 | $1.24M | 0.01% | +138,279 | New |
| Bridgeway Capital Management, LLC | 145,611 | $1.31M | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 215,156 | $1.93M | 0.00% | +18,490+9.4% | Added |
| State Street Corp | 220,621 | $1.98M | 0.00% | +14,609+7.1% | Added |
| Paradigm Biocapital Advisors LP | 336,229 | $3.02M | 0.80% | +336,229 | New |
| Renaissance Technologies LLC | 386,094 | $3.46M | 0.00% | −200−0.1% | Reduced |
| Artal Group S.A. | 593,030 | $5.32M | 0.22% | 00.0% | Unchanged |
| Vanguard Group Inc | 707,598 | $6.35M | 0.00% | +9,844+1.4% | Added |
| BlackRock Inc. | 723,138 | $6.49M | 0.00% | −5,710−0.8% | Reduced |
| TCG Crossover Management, LLC | 1,034,222 | $9.28M | 3.72% | −135,990−11.6% | Reduced |
| Avidity Partners Management LP | 1,207,000 | $10.8M | 0.24% | −138,000−10.3% | Reduced |
| Lynx1 Capital Management LP | 1,484,693 | $13.3M | 12.37% | +222,766+17.7% | Added |
| BVF Inc | 1,589,495 | $14.3M | 0.57% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 2,029,580 | $18.2M | 3.73% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,081,592 | $36.6M | 0.59% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 4,185,757 | $37.5M | 3.20% | +4,185,757 | New |
| Decheng Capital Management III (Cayman), LLC | 4,708,288 | $42.2M | 12.94% | +4,708,288 | New |
| Frazier Management LLC | 0 | $0 | 0.00% | −1,784,913−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,120,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −23,079−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Western Wealth Management, LLC | 0 | $0 | 0.00% | −12,360−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −10,875−100.0% | Sold out |